Skip to main content

Table 1 Baseline characteristics of the patients

From: Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study

Characteristics

AC group(n = 67)

No. (%), Mean ± SD, Median (range)

AT group(n = 54)

No. (%), Mean ± SD, Median (range)

p value

Age

61.4 ± 8.5

58.2 ± 9.3

0.055

BMI, kg/m2

25.5 (23.5, 27.5)

25.7 (24.1, 28.0)

0.257

Sex, male

50 (74.6%)

44 (81.5%)

0.368

Prior PCI

10 (14.9%)

19 (16.7%)

0.794

Atrial fibrillation

2 (3.0%)

2 (3.7%)

Hypertension

45 (67.2%)

34 (64.8%)

0.786

Dyslipidemia

56 (83.6%)

50 (92.6%)

0.135

Diabetes mellitus

30 (44.8%)

21 (38.9%)

0.514

Cerebrovascular event

11 (16.4%)

11 (20.4%)

0.575

Chronic kidney failure

2 (3.0%)

1 (1.9%)

Smoking

39 (58.2%)

40 (74.1%)

0.068

Prior cardiac surgery

1 (1.5%)

1 (1.9%)

Prior myocardial infarction

32 (47.8%)

16 (29.6%)

0.043a

Triple-vessel disease

49 (73.1%)

32 (59.3%)

0.107

NYHA class III or IV

29 (43.3%)

31 (57.4%)

0.122

Preoperative EF, %

62.0 (57.0–66.0)

60.0 (56.0–65.0)

0.449

  1. BMI body mass index, EF ejection fraction, No. number, NYHA New York Heart Association, PCI percutaneous coronary intervention, SD standard deviation
  2. a Statistically significant